Boston Scientific Corporation (BSX)

Boston Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Revenue	5,203	5,286	5,065	5,061	4,663	4,561	4,209	4,120	3,856	3,725	3,527	3,599	3,389	3,242	3,170	3,244	3,026	3,127	2,932	3,077
Revenue Growth (YoY)	11.58%	15.90%	20.34%	22.84%	20.93%	22.44%	19.34%	14.48%	13.78%	14.90%	11.26%	10.94%	12.00%	3.68%	8.12%	5.43%	9.96%	15.43%	10.27%	53.62%
Cost of Revenue	1,590	1,608	1,523	1,637	1,453	1,466	1,312	1,270	1,209	1,147	1,101	1,058	1,040	1,011	979	1,011	955	972	900	945
Gross Profit	3,614	3,679	3,542	3,424	3,210	3,095	2,897	2,850	2,648	2,579	2,426	2,542	2,349	2,232	2,191	2,233	2,071	2,155	2,032	2,132
Selling, General & Admin	1,781	1,834	1,741	1,716	1,597	1,612	1,562	1,446	1,364	1,379	1,242	1,354	1,215	1,163	1,132	1,165	1,060	1,153	1,066	1,121
Depreciation & Amortization Expenses	232	228	225	225	219	225	205	213	214	208	208	210	203	199	202	204	198	192	184	180
Research & Development	516	569	514	526	443	459	407	383	366	363	356	359	337	330	339	335	319	320	310	298
Other Operating Expenses	-15	29	15	138	29	122	-10	288	30	44	-72	104	43	117	160	107	28	309	85	271
Total Operating Expenses	2,514	2,660	2,495	2,605	2,288	2,418	2,164	2,330	1,974	1,994	1,734	2,027	1,798	1,809	1,833	1,811	1,605	1,974	1,645	1,870
Operating Income	1,101	825	1,048	819	921	675	733	520	675	584	693	514	552	402	358	423	466	180	387	262
Interest Expense	-90	-90	-87	-90	-82	-80	-79	-77	-69	-65	-66	-70	-65	-64	-63	-64	-279	-87	-86	-86
Other Non-Operating Income (Expense)	151	-35	-23	213	-34	-9	14	-23	2	-15	-18	-18	-43	58	-51	-14	-31	26	181	-26
Total Non-Operating Income (Expense)	61	-125	-110	123	-116	-89	-65	-100	-67	-80	-84	-88	-108	-6	-114	-78	-310	-61	95	-112
Pretax Income	1,162	700	939	941	805	585	669	420	608	505	610	426	444	396	245	345	156	119	483	149
Provision for Income Taxes	-176	30	183	146	133	23	200	98	115	1	105	156	131	255	57	85	45	26	64	-37
Net Income	1,341	672	755	797	674	565	469	324	495	505	505	261	300	126	174	246	97	80	405	172
Minority Interest in Earnings	-2	-2	0	-2	-2	-4	0	-2	-1	-1	0	-	-	-	-	-	-	-	-	-
Net Income Attributable to Preferred Dividends	-	-	-	-	-	-	-	-	-	0	-	9	14	13	14	14	14	13	14	14
Net Income to Common	1,341	672	755	797	674	565	469	324	495	505	505	261	300	126	174	246	97	80	405	172
Net Income Growth	98.96%	18.94%	60.98%	145.99%	36.16%	11.88%	-7.13%	24.14%	65.00%	300.79%	190.23%	6.10%	209.28%	57.50%	-57.04%	43.02%	-70.34%	-59.18%	-	-
Shares Outstanding (Basic)	1,485	1,483	1,482	1,480	1,477	1,474	1,473	1,471	1,468	1,465	1,465	1,446	1,436	1,433	1,432	1,430	1,428	1,425	1,424	1,421
Shares Outstanding (Diluted)	1,495	1,496	1,496	1,494	1,493	1,490	1,487	1,484	1,482	1,477	1,475	1,456	1,446	1,442	1,440	1,438	1,438	1,436	1,436	1,433
Shares Change (YoY)	0.13%	0.38%	0.55%	0.63%	0.77%	0.90%	0.84%	1.92%	2.47%	2.39%	2.43%	1.28%	0.53%	0.43%	0.31%	0.37%	0.53%	-0.30%	0.33%	1.53%
EPS (Basic)	0.90	0.45	0.51	0.54	0.46	0.38	0.32	0.22	0.34	0.34	0.34	0.18	0.21	0.09	0.12	0.17	0.07	0.06	0.28	0.12
EPS (Diluted)	0.90	0.45	0.51	0.53	0.45	0.38	0.32	0.22	0.33	0.34	0.34	0.18	0.21	0.09	0.12	0.17	0.07	0.06	0.28	0.12
EPS Growth	100.00%	18.42%	59.38%	140.91%	36.36%	11.77%	-5.88%	22.22%	57.14%	277.78%	183.33%	5.88%	200.00%	50.00%	-57.14%	41.67%	-69.56%	-57.14%	-	-
Shares Outstanding	1,486	1,483	1,482	1,480	1,479	1,475	1,473	1,471	1,469	1,465	1,464	1,464	1,438	1,433	1,432	1,432	1,430	1,425	1,425	1,427
Free Cash Flow	171	1,013	1,162	1,129	354	1,179	823	658	-15	690	508	515	79	595	320	202	-179	212	358	537
Free Cash Flow Growth	-51.70%	-14.08%	41.19%	71.58%	-	70.87%	62.01%	27.77%	-	15.97%	58.75%	154.95%	-	180.66%	-10.62%	-62.38%	-	-58.76%	-39.73%	167.16%
Free Cash Flow Per Share	0.11	0.68	0.78	0.76	0.24	0.79	0.55	0.44	-0.01	0.47	0.34	0.35	0.05	0.41	0.22	0.14	-0.12	0.15	0.25	0.37
Gross Margin	69.46%	69.60%	69.93%	67.65%	68.84%	67.86%	68.83%	69.17%	68.67%	69.23%	68.78%	70.63%	69.31%	68.85%	69.12%	68.83%	68.44%	68.92%	69.30%	69.29%
Operating Margin	21.16%	15.61%	20.69%	16.18%	19.75%	14.80%	17.42%	12.62%	17.51%	15.68%	19.65%	14.28%	16.29%	12.40%	11.29%	13.04%	15.40%	5.76%	13.20%	8.51%
Profit Margin	25.74%	12.68%	14.91%	15.71%	14.41%	12.32%	11.12%	7.82%	12.79%	13.53%	14.32%	7.50%	9.24%	4.35%	5.93%	8.01%	3.67%	2.97%	14.29%	6.04%
FCF Margin	3.29%	19.16%	22.94%	22.31%	7.59%	25.85%	19.55%	15.97%	-0.39%	18.52%	14.40%	14.31%	2.33%	18.35%	10.09%	6.23%	-5.92%	6.78%	12.21%	17.45%
EBITDA	1,452	1,190	1,390	1,155	1,246	1,023	1,039	831	979	897	993	812	837	696	642	707	740	470	659	525
EBITDA Margin	27.91%	22.51%	27.44%	22.82%	26.72%	22.43%	24.69%	20.17%	25.39%	24.08%	28.15%	22.56%	24.70%	21.47%	20.25%	21.79%	24.45%	15.03%	22.48%	17.06%
EBIT	1,101	825	1,048	819	921	675	733	520	675	584	693	514	552	402	358	423	466	180	387	262
EBIT Margin	21.16%	15.61%	20.69%	16.18%	19.75%	14.80%	17.42%	12.62%	17.51%	15.68%	19.65%	14.28%	16.29%	12.40%	11.29%	13.04%	15.40%	5.76%	13.20%	8.51%
Effective Tax Rate	-15.15%	4.29%	19.49%	15.52%	16.52%	3.93%	29.90%	23.33%	18.91%	0.20%	17.21%	36.62%	29.50%	64.39%	23.27%	24.64%	28.85%	21.85%	13.25%	-24.83%

Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q